InvestorsHub Logo
Followers 23
Posts 3339
Boards Moderated 0
Alias Born 08/05/2019

Re: None

Wednesday, 10/21/2020 10:15:46 AM

Wednesday, October 21, 2020 10:15:46 AM

Post# of 190
https://finance.yahoo.com/news/3-penny-stocks-massive-upside-193058024.html

NEOS an Outperform (i.e. Buy) along with an $8 price target.

“Adzenys XR-ODT has experienced impressive prescription growth over the course of the past year, and is now the preferred ADHD alternative dosage form taking over from Pfizer's market-leading Quillivant XR as its new-to-brand market share reached the number 1 position.”